Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Aeon Metals (AMLN)

Aeon Metals Limited
Date:
Sort by:
 Showing the most relevant articles for your search:ASX:AMLN
DateTimeSourceHeadlineSymbolCompany
29/10/200912:34Dow Jones NewsUPDATE: Roche's New Diabetes Drug Works Better Than ByettaLSE:AMLNAmylin Pharmaceuticals Inc.
29/10/200909:02Dow Jones NewsRoche: New Diabetes Drug Works Better Than Byetta - StudyLSE:AMLNAmylin Pharmaceuticals Inc.
19/10/200921:21Dow Jones News2ND UPDATE:Galleon Holdings Include OSI Pharma,Huron ConsultingLSE:AMLNAmylin Pharmaceuticals Inc.
19/10/200920:17Dow Jones NewsUPDATE: Galleon Holdings Include OSI Pharma, Huron ConsultingLSE:AMLNAmylin Pharmaceuticals Inc.
19/10/200920:05Dow Jones NewsGalleon Holdings Include OSI Pharmaceuticals, Huron ConsultingLSE:AMLNAmylin Pharmaceuticals Inc.
30/09/200910:16Dow Jones NewsNovo Nordisk's Diabetes Drug Victoza Successful In StudyLSE:AMLNAmylin Pharmaceuticals Inc.
06/08/200912:28Dow Jones NewsNovo Nordisk CEO: Positive Victoza Reception In EuropeLSE:AMLNAmylin Pharmaceuticals Inc.
21/07/200921:20Dow Jones NewsAmylin 2Q Loss Narrows On Cost-Cutting; Byetta Sales SlipLSE:AMLNAmylin Pharmaceuticals Inc.
03/07/200911:01Dow Jones NewsUPDATE: Novo Nordisk Diabetes Drug Victoza Gets EU ApprovalLSE:AMLNAmylin Pharmaceuticals Inc.
03/07/200910:06Dow Jones NewsNovo Nordisk's Victoza To Reach Market In A Few Weeks - CSOLSE:AMLNAmylin Pharmaceuticals Inc.
09/06/200910:30Dow Jones NewsDoctors Say New Diabetes Drugs Hold Great PromiseLSE:AMLNAmylin Pharmaceuticals Inc.
09/06/200907:13Dow Jones NewsCORRECT: Study: Novo Nordisk's Diabetes Drug Beats Lilly's ByettaLSE:AMLNAmylin Pharmaceuticals Inc.
09/06/200907:12Dow Jones NewsNovo Nordisk Diabetes Drug Liraglutide Successful In StudyLSE:AMLNAmylin Pharmaceuticals Inc.
09/06/200907:12Dow Jones NewsStudy: Novo Nordisk's Diabetes Drug Beats Lilly's ByettaLSE:AMLNAmylin Pharmaceuticals Inc.
07/06/200900:00Dow Jones NewsUPDATE: Weekly Diabetes Drug Byetta Outdoes CompetitorsLSE:AMLNAmylin Pharmaceuticals Inc.
06/06/200919:22Dow Jones NewsStudy Shows Weekly Byetta Diabetes Drug Outdoes CompetitorsLSE:AMLNAmylin Pharmaceuticals Inc.
02/06/200917:59Dow Jones NewsUPDATE: Amylin: 2 Dissidents To Replace Chairman, Lead DirLSE:AMLNAmylin Pharmaceuticals Inc.
02/06/200917:36Dow Jones NewsAmylin: 2 Dissidents To Replace Chairman, Lead DirectorLSE:AMLNAmylin Pharmaceuticals Inc.
27/05/200920:37Dow Jones NewsUPDATE: Amylin: Dissidents Likely Got Up To Two Board SeatsLSE:AMLNAmylin Pharmaceuticals Inc.
27/05/200920:05Dow Jones NewsEastbourne Claims Success In Electing Directors To Amylin BoardLSE:AMLNAmylin Pharmaceuticals Inc.
21/05/200919:02Dow Jones NewsHedge Fund Mgr Schoenfeld Backs Icahn/Eastbourne Amylin SlateLSE:AMLNAmylin Pharmaceuticals Inc.
18/05/200912:17Dow Jones NewsMore Proxy Advisers Back Dissidents' Amylin Board NomineesLSE:AMLNAmylin Pharmaceuticals Inc.
15/05/200922:24Dow Jones NewsUPDATE: Risk Metrics Backs Three Dissident Amylin DirectorsLSE:AMLNAmylin Pharmaceuticals Inc.
15/05/200921:53Dow Jones NewsRisk Metrics Backs Three Dissident Directors For Amylin BoardLSE:AMLNAmylin Pharmaceuticals Inc.
14/05/200915:13Dow Jones NewsUPDATE: Icahn Fires Back At Amylin Over Latest LetterLSE:AMLNAmylin Pharmaceuticals Inc.
04/05/200921:29Dow Jones NewsAmylin To Trim Sales Team by 35%, Sees $45 Million Savings In '10LSE:AMLNAmylin Pharmaceuticals Inc.
30/04/200918:55Dow Jones NewsDEALWATCH: Lilly Can't Afford To Double Down With AmylinLSE:AMLNAmylin Pharmaceuticals Inc.
28/04/200920:03Dow Jones NewsAmylin Proxy Battle Adds To Debate Over What Makes A 'Group'LSE:AMLNAmylin Pharmaceuticals Inc.
24/04/200909:47Dow Jones NewsUPDATE: Novo Nordisk Has Big Hopes For EU Victoza LaunchLSE:AMLNAmylin Pharmaceuticals Inc.
20/04/200919:01Dow Jones NewsUPDATE: US Drug Stocks Flee Into Negative TerritoryLSE:AMLNAmylin Pharmaceuticals Inc.
 Showing the most relevant articles for your search:ASX:AMLN